The efficacy and safety of pharmacotherapy for girls with central precocious puberty or early normal puberty: a retrospective cohort study

Abstract The Chinese Expert Consensus on central precocious puberty (CPP) defines girls’ rapid sexual development before age 8 as CPP; while after age 8 as early normal puberty (ENP). And the use of recombinant human growth hormone (rhGH) for CPP and ENP is off-label and lacks reliable evidence for...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chunsong Yang, Xi Huang, Zheng Liu, Linan Zeng, Jin Wu, Lingli Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-08-01
coleção:	Scientific Reports
Assuntos:	Gonadotropin-releasing hormone agonist Recombinant human growth hormone Central precocious puberty Early normal puberty Retrospective cohort study
Acesso em linha:	https://doi.org/10.1038/s41598-025-02740-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!